# Dimers Lab

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dimers-lab

- Industry: Internet
- Headquarters: Tokyo, Japan
- Website: www.dimers-lab.com
- Total disclosed funding: $0.3M
- Latest round: Seed (Nov 30, 2012)
- Investors on record: 2

## About

Dimers Lab Inc is a biopharmaceutical company focused on developing innovative diagnostic tools and therapeutic products to enhance disease detection and treatment accuracy for healthcare providers and research institutions.Dimers Lab Inc specializes in the biopharmaceutical sector by creating proprietary diagnostic tools. Founded by Hideaki Nagano, the company has its headquarters in Tokyo, Japan. In November 2012, Dimers Lab raised USD 0.24 mn in Seed funding from SMBC Venture Capital, marking its second deal.Dimers Lab specializes in innovative solutions within the biopharmaceutical sector, focusing on the development of proprietary diagnostic tools and therapeutic products. Their flagship offerings include advanced assays designed for precision medicine, which enhance the accuracy of disease detection and treatment efficacy. These products are tailored for healthcare providers and research institutions aiming to streamline patient care by providing timely and accurate diagnostics. Dimers Lab's customer base predominantly consists of hospitals, diagnostic labs, and pharmaceutical companies across North America and Europe, where the demand for high-quality diagnostic solutions is rapidly growing. The company’s products are strategically positioned to address critical healthcare challenges such as early disease detection and personalized treatment plans, essential for improving patient outcomes.Dimers Lab generates revenue through a multi-faceted business model that includes direct sales and partnerships with healthcare organizations. The company engages in B2B transactions, providing its diagnostic products to hospitals and laboratories on a contractual basis, while also exploring subscription-based offerings for continuous support and updates of their technology. Pricing structures are established based on clients' specific needs, often resulting in tiered pricing plans that cater to different levels of service and product access. Consequently, flagship products are marketed through volume pricing for larger institutional clients and customized pricing for specialized services. This revenue model ensures a consistent cash flow and fosters long-term relationships with clients who rely on Dimers Lab's solutions for their diagnostic needs.Dimers Lab plans to utilize the recent Seed funding of USD 0.24 mn raised in November 2012 to support the development of new diagnostic products aimed at enhancing patient care. The company is targeting expansion into new markets in Asia and Europe by 2025. Upcoming products include advanced diagnostic tools that are currently in the design phase, aimed at addressing emerging healthcare challenges.

## Funding rounds

- Seed, Nov 30, 2012, $0.2M — SMBC Venture Capital
- Seed, Feb 24, 2012, $0.1M — Samurai Incubate

## Investors

- Samurai Incubate (https://capitalatlas.ai/funds/samurai-incubate) — Seed
- SMBC Venture Capital (https://capitalatlas.ai/funds/smbc-venture-capital) — Seed